Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Glatiramer (pen) 2026-05-21
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For Drugs With The Active Ingredient Aflibercept, With The Exception Of 114.3 Mg/ml (atc Code: S01la05). 2026-05-21
Germany Drug Contracts With An Option To Join 2026-05-21
Germany Open House Biologics Discount Agreements 2025-34 - Eculizumab 2026-05-22
Germany Conclusion Not Excluding Drug Discount Agreement. According To Section 130a Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Timolol (atc Code According To Who: S01ed01) 2026-05-23
Germany Conclusion Not Excluding Drug Discount Agreement. In Accordance With Section 130a Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Alfacalcidol (atc Code According To Who: A11cc03) In The Dosage Form Soft Capsules 2026-05-23
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Formoterol + Beclometasone (exclusively Dafo. Ihp, Inh), Atc R03ak08 For The Period January 1st, 2026 - December 31st, 2027 2026-05-23
Germany Open House Biologics Discount Agreements 2025-37 - Peginterferon Alfa-2a 2026-05-23
Germany Contrast Media - Cross-drug Open House Procedure For The Kv Region Of Westphalia-lippe 2026-05-23
Germany Open House Biologics Discount Agreements 2025-36 - Natalizumab (dosage Form For Subcutaneous Injection) 2026-05-23
Whats app